AMELIA SCHROEDER: Open Payments
NPI 1720694771 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,040 in 113 payments from 23 companies in 2025. Trend: 2023 $2,019 · 2024 $1,900 · 2025 $4,040
Food & beverage: $3,271Travel & lodging: $714Education: $55
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 14 | $1,287 |
| AstraZeneca Pharmaceuticals LP | 21 | $672 |
| GlaxoSmithKline, LLC. | 19 | $341 |
| GENZYME CORPORATION | 12 | $291 |
| ANI Pharmaceuticals, Inc. | 5 | $207 |
| Actelion Pharmaceuticals US, Inc. | 3 | $193 |
| Viatris Specialty LLC | 5 | $183 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $163 |
| Regeneron Healthcare Solutions, Inc. | 3 | $113 |
| HARMONY BIOSCIENCES LLC | 4 | $107 |
Products named: INSPIRE, DUPIXENT, FASENRA, TEZSPIRE, NUCALA, PURIFIED CORTROPHIN GEL, YUPELRI, LUMRYZ.
Industry payments across IN — which companies pay providers there.
